HIGHLIGHTS
- who: E. Feldman from the Department for Health Evidence, Radboud University Medical Center, NijmegenInstitute, Antoni Leeuwenhoek, Amsterdam, the Netherlands have published the research: Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure, in the Journal: (JOURNAL)
- what: The aim of this study was to develop a standardized PRO-CTCAE item subset for unambiguously monitoring adverse events in prostate cancer patients. In the third Delphi round, the authors aimed to reach consensus for the final items and to evaluate the included and excluded https://doi.org . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.